Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Motor Activity × pertuzumab × Clear all

Sponsor

Conditions

Breast Neoplasms 52 Ovarian Neoplasms 4 Neoplasms 3 Inflammatory Breast Neoplasms 3 HER2-positive Breast Cancer 3 Carcinoma, Non-Small-Cell Lung 3 Stomach Neoplasms 2 Solid Tumor 2 Rectal Neoplasms 2 Prostatic Neoplasms 2 Neoplasm Metastasis 2 Colonic Neoplasms 2 Urinary Bladder Neoplasms 1 Solid Cancers 1 Patient Preference 1 Pancreatic Neoplasms 1 Neuroendocrine Tumors 1 Neuroblastoma 1 Neoplasms, Unknown Primary 1 Multiple Endocrine Neoplasia 1 Malignant Solid Neoplasm 1 Lung Neoplasms 1 Locally Advanced Breast Cancer 1 Her2-Positive Breast Cancer 1 HER2-positive Metastatic Breast Cancer 1 HER2-positive Early Breast Cancer 1 HER2-Positive Early Breast Cancer 1 HER2 Positive Breast Cancer 1 Fallopian Tube Neoplasms 1 Colorectal Neoplasms 1

Interventions

Exercise 9 Resistance Training 6 Metformin 3 Fitness Trackers 2 secukinumab 1 YES1 protein, human 1 Wearable Electronic Devices 1 Vincristine 1 Therapeutics 1 Thalidomide 1 Surveys and Questionnaires 1 Sugars 1 Standard of Care 1 Platelet Transfusion 1 Physical Therapy Modalities 1 Peripheral Blood Stem Cell Transplantation 1 Nutrition Assessment 1 Methods 1 Melphalan 1 Jogging 1 High-Intensity Interval Training 1 Heparin, Low-Molecular-Weight 1 Green Or 1 Etoposide 1 Erythrocyte Transfusion 1 Epoetin Alfa 1 Dyrk Kinases 1 Doxorubicin 1 Diet Therapy 1 Dexamethasone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡